SHEVONNE CHUDE: Open Payments
NPI 1114273695 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 77 payments from 16 companies in 2025. Trend: 2023 $757 · 2024 $2,728 · 2025 $1,615
Food & beverage: $1,447Education: $168
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $272 |
| ABBVIE INC. | 13 | $194 |
| GENZYME CORPORATION | 9 | $194 |
| Janssen Biotech, Inc. | 9 | $192 |
| UCB, Inc. | 6 | $145 |
| Incyte Corporation | 8 | $138 |
| Amgen Inc. | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 2 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| PFIZER INC. | 3 | $49 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, OPZELURA, Bimzelx, RINVOQ, SKYRIZI, OTEZLA.
Industry payments across MD — which companies pay providers there.
